Archive: 25/10/2018

Innovative gene therapy trial for Parkinson's disease

A trial for a new gene therapy, known as AXO-Lenti-PD, aimed at improving the supply of dopamine in the brains of people with Parkinson's disease has been launched by researchers at UCL and University College London Hospitals ...

page 10 from 10